Stéphane Le Vu

6PUBLICATIONS
26CO-AUTHORS
Medical infection agents (incl. prions)Epidemiological modellingNanotoxicology, health and safetyVeterinary virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 04, 2024
Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis.

Stéphane Le Vu, Marion Bertrand, Laura Semenzato

|Oct 03, 2023
Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study.

Stéphane Le Vu, Marion Bertrand, Jérémie Botton

|Aug 22, 2022
Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.

Jérémie Botton, Marie Joelle Jabagi, Marion Bertrand

|Jun 25, 2022
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines.

Stéphane Le Vu, Marion Bertrand, Marie-Joelle Jabagi

|May 22, 2021
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.

Stéphane Le Vu, Gabrielle Jones, François Anna

Pageof 1